Shanghai Serum Bio Technology Co (SHSE:688163) COGS-to-Revenue : 0.29 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shanghai Serum Bio Technology Co COGS-to-Revenue?

Shanghai Serum Bio Technology Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥7.5 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥26.3 Mil.

Shanghai Serum Bio Technology Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shanghai Serum Bio Technology Co's Gross Margin % for the three months ended in Mar. 2024 was 71.46%.

Shanghai Serum Bio Technology Co COGS-to-Revenue Historical Data

The historical data trend for Shanghai Serum Bio Technology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Serum Bio Technology Co COGS-to-Revenue Chart

Shanghai Serum Bio Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.14

0.16

0.24

Shanghai Serum Bio Technology Co Quarterly Data
	Dec16	Dec17	Dec18	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.30	0.23	0.21	0.33	0.29

Shanghai Serum Bio Technology Co COGS-to-Revenue Calculation

Shanghai Serum Bio Technology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	46.187	/	190.144
	=	0.24

Shanghai Serum Bio Technology Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	7.505	/	26.301
	=	0.29

Shanghai Serum Bio Technology Co (SHSE:688163) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shanghai Serum Bio Technology Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	7.505 / 26.301
	=	71.46 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shanghai Serum Bio Technology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Serum Bio Technology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Serum Bio Technology Co (SHSE:688163) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1288, Huaqing Road, Qingpu District, Shanghai, CHN, 201707

Website

http://www.serum-china.com.cn

Shanghai Serum Bio Technology Co Ltd is engaged in the research, development, production and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety.

Shanghai Serum Bio Technology Co (SHSE:688163) Headlines

No Headlines